跳到正文
Pharmaceutical Microbiology Resources·· 1 天前AI 评分31

专家解读:实时空气监测中的BFPC应用(EU GMP Annex 1)

Expert insights on BFPCs for Real-Time Air Monitoring

AI 导读

欧盟GMP附录1要求A级环境在关键工艺全过程中持续进行活性空气监测,其近期修订改变了监管对实时检测的态度。本次网络研讨会将讨论生物荧光粒子计数器(BFPC)在哪些场景可简化工作流程、提升生产效率并满足当前及未来监管要求,以及需克服的挑战。议题涵盖A级环境实时监测、BFPC与传统采样结合、监管与验证及运营挑战、整合与确认及成本效益考量。

正文

Recent regulatory changes and technological advances are leading pharmaceutical manufacturers to consider new technologies for microbial air monitoring. EU GMP Annex 1 requires continuous viable air monitoring in Grade A environments for the full duration of critical processing, and its recent revision has changed regulatory attitudes toward real-time detection. Manufacturing is evolving, too: novel biologicals are increasingly being produced with minimal operator intervention in gloved or even gloveless isolators.

These developments have catalyzed broader interest in advanced biofluorescent particle counters (BFPCs) for fluorescence-based continuous active air monitoring in real-time, available in combination with integrated traditional microbial air sampling onto plates. In this webinar, our panel of environmental monitoring specialists will discuss in which settings a BFPC can streamline workflows to boost manufacturing productivity while meeting present and future regulatory demands, and the challenges that need to be overcome.

During the webinar, you will:

  • Discover real-time air monitoring in Grade A environments under the latest EU Annex 1.
  • Learn how BFPCs pair with traditional sampling to enable real-time decisions.
  • Understand regulatory, validation, and operational challenges.
  • Explore practical options for integration, qualification, and cost/benefit considerations.

To register go to: BFPCs.

Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)

来源:Pharmaceutical Microbiology Resources · pharmamicroresources.com